Role of CCR2 in Inflammatory Conditions of the Central Nervous System. Issue 9 (September 2014)

• Record Type: Journal Article
• Authors: Chu, Hannah X; Arumugam, Thiruma V; Gelderblom, Mathias; Magnus, Tim; Drummond, Grant R; Sobey, Christopher G
• Is Part Of: Journal of cerebral blood flow & metabolism. Volume 34:Issue 9(2014)
• Page Start: 1425
• Page End: 1429
• Publication Date: 2014-09
• Subjects: chemokine receptor CC2 -- CNS inflammation -- ischemic stroke -- monocytes -- multiple sclerosis; Cerebral circulation -- Periodicals; Brain -- Metabolism -- Periodicals; Brain -- Blood-vessels -- Periodicals; Cerebrovascular disease -- Periodicals; 612.824
• DOI: 10.1038/jcbfm.2014.120
• Languages: English
• ISSNs: 0271-678X

Abstract

CC chemokine receptor 2 (CCR2) plays important roles in extravasation and transmigration of monocytes under inflammatory conditions. CCR2 and its ligands have been extensively studied in a range of inflammatory diseases in the central nervous system (CNS), including multiple sclerosis, Alzheimer's disease and ischemic stroke. This brief review summarizes our current understanding of the physiologic and pathologic roles of CCR2, focusing on its involvement in CNS inflammatory diseases. There appears to be a rationale for exploring therapies involving CCR2 inhibition in multiple sclerosis and ischemic stroke, but there is also evidence for immunomodulatory and protective effects of CCR2 activity during CNS inflammation. The critical balance between protective and detrimental roles of CCR2-dependent recruitment of leukocytes must therefore be carefully examined to guide safe and effective development of any therapies involving CCR2 modulation.